WebNov 30, 2024 · GSK today announced that Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3 December 2024. Phil will report to Dr Hal Barron, Chief Scientific Officer and President R&D, and join GSK’s R&D Leadership Team, and the Vaccines Leadership Team. Phil will be based in Greater Boston, Massachusetts, US. WebHow much do GSK employees make? Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. Research & Science Based on 1455 salaries Investigator 257 salaries Senior Scientist 171 salaries View More Business Based on 578 salaries Director 154 salaries Manager 84 salaries View More Sales
VP, Global Head of RMA - Regulatory R&D - GSK - LinkedIn
WebThis page is intended for GSK employees only. Please note that to access connectGSK, you need to connect to the corporate network using Junos Pulse. You can access the GSK … WebGSK Investor Relations. Institutional investment questions. 2929 Walnut St Ste 1700 Philadelphia, PA 19104. Tel:+1 215 751 4611 Email:[email protected]. Shareholder questions Additional contacts. Annual Report order line Tel: +1 888 825 5249 heated jumpers australia
GSK’s top scientist jumps ship in new blow for pharmaceutical firm
WebJan 19, 2024 · GSK said Tony Wood will become CSO designate and assume full accountability for Research and Development (R&D) on Aug. 1, adding that Barron will become a GSK non-executive director on that... WebGSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. WebHead of Business Development, Respiratory, InflammationandAutoimmune Therapy Area @ AstraZeneca Vice President, Business Development, Metabolic PathwaysandCardiovascular Therapy Area Unit @ GSK see more Education University of Delaware Ph.D. (Molecular Virology) 1992 - 1996 University of Delaware M.S. (Molecular Virology) 1987 - 1989 heated kang